|
G1: device manufacturer address 1: 600 mts.Oeste de entrada, principal ave.Las americas, parque industrial.Should additional relevant information become available, a supplemental report will be submitted.
|
|
B5: upon additional information, the events occur during chemotherapy types (cytoxin, keytruda, trastuzumab,5fu, oxaliplatin, irinotecan) infusions via 250 and 500 viaflex bags.¿the bag and drip chamber had collapsed towards the end of the infusion as if there was a large suction on the line, however, there was still med in the drip chamber and in the line above the pump.¿ ¿at times there is a little solution left in the bag (5 ml was mentioned) but mostly in the line/drip chamber.¿ h10: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|